Hydroxyurea Adherence for Personal Best in Sickle Cell Treatment: HABIT

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Sickle Cell Disease
Interventions
BEHAVIORAL

Community Health Worker (CHW)

CHWs will have scheduled interactions with subjects at home, by telephone or at Community League of the Heights (CLOTH), our partner community-based organization (CBO). CHWs will customize text messaging jointly with each youth and parent (Month 3) and text message reminders to both parent and youth will be implemented during Months 4-6. Subjects lacking a mobile phone or sufficient cell phone plan will be compensated to purchase or upgrade plans to accommodate texts.

BEHAVIORAL

Education

Dyads randomized to the control group will continue usual clinic-based care, including monitoring and review of HbF levels, and similar frequency of clinic visits and access to sickle cell team staff. They will be provided with educational materials about sickle cell disease and hydroxyurea use for children.

Trial Locations (2)

10032

Columbia University Medical Center, New York

10461

Montefiore Medical Center - Albert Einstein College of Medicine, The Bronx

All Listed Sponsors
collaborator

National Institute of Nursing Research (NINR)

NIH

collaborator

Montefiore Medical Center

OTHER

lead

Columbia University

OTHER

NCT02029742 - Hydroxyurea Adherence for Personal Best in Sickle Cell Treatment: HABIT | Biotech Hunter | Biotech Hunter